Why the study?
New diagnostic methods allow detailed study of eye damage in malignant arterial hypertension and analysis of relationships between ocular and systemic manifestations to determine visual involvement and prognostic signs.
Key points are not available for this paper at this time.
Design
Review
May enhance microvascular assessment in malignant hypertension; leaves open routine adoption pending prospective validation.
Malignant arterial hypertension is a clinical syndrome characterized by severe diastolic arterial hypertension with signs of ischemic damage to target organs - kidneys, heart, brain, eyes. Malignant arterial hypertension can be one of the reasons, as well as a consequence of thrombotic microangiopathy - a special type of vascular lesions of the organ microvasculature. Ocular manifestations of arterial hypertension include hypertensive retinopathy of varying severity, choriopathy. The appearance of new diagnostic research methods allows a detailed study of eye damage in malignant arterial hypertension, whether associated or not with thrombotic microangiopathy, and to analyze the relationship of ocular and systemic manifestations of this disease to determine the nature and degree of involvement of the organ of vision in the pathological process and identify prognostic signs of disease progression and its forms.
No takes yet. Share an insight, caveat, or question.
Шелудченко et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: